Sanaz Memarzadeh is an Oncology physician affiliated with University of California, Los Angeles. OpenAlex indexes 176 publications with 3,294 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
Suite 430
Los Angeles, CA 900950001
Telephone
310-794-7274Registry record last updated 12 Feb 2015.
Clinical trials
- Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)
Sponsor: Jonsson Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
8 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer
University of California Los Angeles
FY2026$681,545R01CA287673 - Exploring super charged NK cells as a novel cell-based immune therapy in targeting platinum resistant ovarian cancers
Va Greater Los Angeles Healthcare System
FY2026I01BX006411 - Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer
University of California Los Angeles
FY2025$681,544R01CA287673
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity
Proceedings of the National Academy of Sciences
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Zev Wainberg, MD
University of California, Los Angeles
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”